Reevaluation of the prevalences of serum autoantibodies reactive with '64-kd eye muscle proteins' in patients with thyroid-associated ophthalmopathy

Thyroid

Volumn 8, Issue 2, 1998, Pages 175-179

  Kubota, S ^a   Gunji, K ^a   Stolarski, C ^a   Kennerdell, J S ^a   Wall, J ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALSEQUESTRIN; MUSCLE PROTEIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SWINE;

EID: 0031940128     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.175     Document Type: Article

References (20)

1. Weetman AP 1991 Thyroid-associated eye disease: Pathophysiology. Lancet 338:25-28.
2. Burch H, Wartofsky L 1993 Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endoc Rev 14:747-793.
3. Wall JR, Bernard N, Boucher A, Salvi M, Zhang ZG, Kennerdell J, Tyutyunikov A, Genovese C 1993 Pathogenesis of thyroid-associated ophthalmopathy: An autoimmune disorder of the eye muscle associated with Graves' hyperthyroidism and Hashimoto's thyroiditis. Clin Immunol Immunopathol 68:1-8.
4. Miller A, Arthurs B, Boucher A, Liberman A, Bernard N, Salvi M, Wall JR 1992 Significance of antibodies reactive with a 64 kDa eye muscle membrane antigen in patients with thyroid autoimmunity. Thyroid 2:197-202.
5. Salvi M, Miller A, Wall JR 1988 Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy. FEBS Lett 232:135-139.
6. Salvi M, Bernard N, Miller A, Zhang ZG, Gardini E, Wall JR 1991 Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Thyroid 1:207-213.
7. Hiromatsu Y, Sato M, Tanaka K, Shoji S, Nonaka K, Chinami M, Fukazawa H 1993 Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative Western blot. Autoimmunity 14:1-8.
8. Nebes V, Sato M, Gunji K, Boucher A, Stolarski CS, Kubota S, Wall JR 1996 Molecular cloning and characterization of a 64 kDa eye muscle autoantigen associated with thyroid-associated ophthalmopathy [abstract]. Proceedings of the Sixty-ninth Annual Meeting of the American Thyroid Association, San Diego, November 1996.
9. Dong Q, Ludgate M, Vassart G 1991 Cloning and sequencing of a novel 64-kDa autoantigen recognized by patients with autoimmune thyroid disease. J Clin Endocrinol Metab 72:1375-81.
10. Committees of the American, European, Asia-Oceania and Latin America Thyroid Associations 1992 Classification of eye changes of Graves' disease. Thyroid 2:235-6.
11. Laemmli UK 1970 Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680-681.
12. Kiljanski J, Nebes V, Wall JR 1995 The ocular muscle the target of the immune system in endocrine ophthalmopathypro Int Arch Allerg Immunol 106:204-212.
13. Kendal-Taylor P, Petros P 1989 Circulating retrobulbar antibodies in Graves' ophthalmopathy. Acta Endocrinologica 121(suppl 2):31-37.
14. Ahmann A, Baker JR, Weetman AP, Wartofsky L, Nutman TB, Burman KD 1987 Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: Identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme linked immunosorbent assay. J Clin Endocrinol Metab 64:454-60.
15. Schifferdecker E, Ketzler-Sasse U, Boehm BO, Ronsheimer HB, Scherbaum WA, Schoffling K 1989 Re-evaluation of eye muscle autoantibody determination in Graves' ophthalmopathy: Failure to detect a specific antigen by use of enzyme-linked immunosorbent assay, indirect immunofluorescence and immunoblotting techniques. Acta Endocrinol 121:643-650.
16. Milner RE, Famulski KS, Michalak M 1992 Calcium binding proteins in the sarcoplasmic/endoplasmic reticulum of muscle and nonmuscle cells. Mol Cell Biochem 112:1-13.
17. Raichman M, Panzeri MC, Clementi E, Papzafiri P, Eckley M, Clegg DO, Villa A, Meldolesi J 1995 Differential localization and functional role of calsequestrin in growing and differentiating myoblasts. J Cell Biol 128:3431-54.
18. Kubota S, Gunji K, Ackrell BAC, Cochran B, Stolarski C, Wengrowicz S, Hiromatsu Y, Kennerdell JS, Wall JR. The 64 kDa eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: the corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism. J Clin Endocrinol Metab (in press).
19. Wu Y-J, Clarke SEM, Shepherd P. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and-other thyroid and non-thyroid disorders. Thyroid (in press).
20. Gunji K, Kubota S, Stolarski C, Wengrowicz S, Kennerdell JS, Wall JR. A 63 kDa skeletal muscle protein associated with eye muscle inflammation in Graves' disease is identified as the calcium binding protein calsequestrin. Autoimmunity (in press).